C. Jillian Tsai

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2020 · 382 citations · Full text

Osteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal Cancer

C. Jillian Tsai, Theresa M. Hofstede, Erich M. Sturgis et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 276 citations · Full text

Radiation Therapy, Medicine, Oropharyngeal Cancer +7

The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience

Adepitan A. Owosho, C. Jillian Tsai, Ryan S. Lee et al. · Oral Oncology · 2016 · 269 citations · Full text

Intensity-modulated Radiation Therapy, Radiation Therapy, Medicine +9

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques

Jonathan E. Leeman, Jingao Li, Xin Pei et al. · JAMA Oncology · 2017 · 236 citations · Full text

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian et al. · The Lancet · 2023 · 214 citations · Full text

Adaptive Radiotherapy, Radiation Therapy, Medicine +9